Background Multidrug-resistant tuberculosis threatens to reverse recent reductions in global
tuberculosis incidence. Although children younger than 15 years constitute more than 25 …

Recommendations on the management of smear-negative pulmonary tuberculosis (TB) are
still based on the behaviour of this disease in populations unaffected by the human …

SETTING: Greater Mymensingh area, Bangladesh. OBJECTIVES: To document among new
tuberculosis (TB) patients the proportions and treatment outcomes of silent, non-disputed …

SETTING: Damien Foundation tuberculosis (TB) control project in Bangladesh. OBJECTIVE:
Early diagnosis of true TB treatment failure and multidrug resistance (MDR) for more efficient …

Background Meta-analyses on impact of isoniazid-resistant tuberculosis informed the World
Health Organization recommendation of a levofloxacin-strengthened rifampicin-based …

Resistance to anti-tuberculosis (anti-TB) antibiotics is a major public health concern for
many high-TB burden countries in Asia, including Bangladesh. Therefore, to represent the …

Abstract Introduction: In Kenya, which ranks thirteenth of 27 high tuberculosis burden
countries, diagnosis is based on Ziehl-Neelsen staining alone and patients are treated …

Multidrug resistant tuberculosis is now thought to afflict between 1 and 2 million patients
annually. Although significant regional variability in the distribution of disease has been …

Despite having 100% coverage of directly observed treatment short-course, multi drug-
resistant (MDR) tuberculosis (TB) is still increasing in Bangladesh. Early detection of MDR …

The magnitude of anti-tuberculosis drug resistance in Bangladesh is not precisely known.
We studied the drug resistance patterns of Mycobacterium tuberculosis in an urban and a …